alembic pharma
Jump to
143 Results Found
  • Alembic Pharma gets five observations from USFDA for Gujarat facility Feb 08, 2021 12:03 PM IST

    Alembic Pharma gets five observations from USFDA for Gujarat facility

    "The United States Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals'' New Injectable Facility (F-3) located at Karkhadi from January 29-February 5, 2021.

  • Neutral Alembic Pharma; target of Rs 1070: Motilal Oswal Feb 02, 2021 09:16 PM IST

    Neutral Alembic Pharma; target of Rs 1070: Motilal Oswal

    Motilal Oswal recommended Neutral rating on Alembic Pharma with a target price of Rs 1070 in its research report dated January 19, 2021.

  • Hold Alembic Pharma; target of Rs 1055: ICICI Direct Jan 28, 2021 03:01 PM IST

    Hold Alembic Pharma; target of Rs 1055: ICICI Direct

    ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 1055 in its research report dated January 20, 2021.

  • Alembic Pharma gets USFDA nod for low blood pressure treatment drug Jan 22, 2021 11:47 AM IST

    Alembic Pharma gets USFDA nod for low blood pressure treatment drug

    The approved product is therapeutically equivalent to the reference listed drug product ProAmatine tablets of Takeda Pharmaceuticals USA, Inc.

  • Alembic Pharma Standalone December 2020 Net Sales at Rs 1,235.77 crore, up 17.43% Y-o-Y Jan 21, 2021 09:22 AM IST

    Alembic Pharma Standalone December 2020 Net Sales at Rs 1,235.77 crore, up 17.43% Y-o-Y

  • Alembic Pharma Consolidated December 2020 Net Sales at Rs 1,314.33 crore, up 8.7% Y-o-Y Jan 21, 2021 09:22 AM IST

    Alembic Pharma Consolidated December 2020 Net Sales at Rs 1,314.33 crore, up 8.7% Y-o-Y

  • Alembic Pharma Standalone December 2020 Net Sales at Rs 1,235.77 crore, up 17.43% Y-o-Y Jan 19, 2021 04:11 PM IST

    Alembic Pharma Standalone December 2020 Net Sales at Rs 1,235.77 crore, up 17.43% Y-o-Y

  • Alembic Pharma Consolidated December 2020 Net Sales at Rs 1,314.33 crore, up 8.7% Y-o-Y Jan 19, 2021 04:11 PM IST

    Alembic Pharma Consolidated December 2020 Net Sales at Rs 1,314.33 crore, up 8.7% Y-o-Y

  • Alembic Pharma share price rises after US FDA nod to metolazone tablets Dec 03, 2020 11:34 AM IST

    Alembic Pharma share price rises after US FDA nod to metolazone tablets

    The company received US Food & Drug Administration final approval for metolazone tablets USP 2.5 mg, 5 mg, and 10 mg.

  • Alembic Pharma Consolidated September 2020 Net Sales at Rs 1,457.10 crore, up 17.43% Y-o-Y Oct 27, 2020 09:41 AM IST

    Alembic Pharma Consolidated September 2020 Net Sales at Rs 1,457.10 crore, up 17.43% Y-o-Y

  • Alembic Pharma Consolidated September 2020 Net Sales at Rs 1,457.10 crore, up 17.43% Y-o-Y Oct 26, 2020 08:31 PM IST

    Alembic Pharma Consolidated September 2020 Net Sales at Rs 1,457.10 crore, up 17.43% Y-o-Y

  • Alembic Pharma Standalone September 2020 Net Sales at Rs 1,400.01 crore, up 23.36% Y-o-Y Oct 26, 2020 08:14 PM IST

    Alembic Pharma Standalone September 2020 Net Sales at Rs 1,400.01 crore, up 23.36% Y-o-Y

  • Buy Alembic Pharma; target of Rs 1170: ICICI Direct Oct 25, 2020 12:05 PM IST

    Buy Alembic Pharma; target of Rs 1170: ICICI Direct

    ICICI Direct is bullish on Alembic Pharma recommended buy rating on the stock with a target price of Rs 1170 in its research report dated October 23, 2020.

  • Buy Alembic Pharma; target of Rs 1180: YES Securities Oct 23, 2020 03:35 PM IST

    Buy Alembic Pharma; target of Rs 1180: YES Securities

    YES Securities is bullish on Alembic Pharma has recommended buy rating on the stock with a target price of Rs 1180 in its research report dated October 22, 2020.

  • Alembic Pharma share price gains as associate company enters agreement to develop Tenalisib Oct 13, 2020 10:32 AM IST

    Alembic Pharma share price gains as associate company enters agreement to develop Tenalisib

    Rhizen Pharmaceuticals announced that it has entered into an exclusive license agreement with Curon Biopharmaceutical Limited. Alembic Pharmaceuticals through its wholly owned subsidiary holds 50 percent ownership in Rhizen.

  • Alembic Pharma share price in the red; company gets tentative FDA nod for BP medicine Sep 07, 2020 11:32 AM IST

    Alembic Pharma share price in the red; company gets tentative FDA nod for BP medicine

    Alembic now has a total of 131 ANDA approvals (113 final approvals and 18 tentative approvals) from USFDA, the company said.

  • Alembic Pharma share price gains after tentative FDA nod for diabetes drug Aug 27, 2020 11:08 AM IST

    Alembic Pharma share price gains after tentative FDA nod for diabetes drug

    The firm has got the nod for empagliflozin and linagliptin tablets. Empagliflozin is indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes.

  • Buy Alembic Pharma; target of Rs 1140: ICICI Direct Jul 24, 2020 04:41 PM IST

    Buy Alembic Pharma; target of Rs 1140: ICICI Direct

    ICICI Direct is bullish on Alembic Pharma has recommended buy rating on the stock with a target price of Rs 1140 in its research report dated July 23, 2020.

  • Buy Alembic Pharma; target of Rs 1180: YES Securities Jul 23, 2020 07:08 PM IST

    Buy Alembic Pharma; target of Rs 1180: YES Securities

    YES Securities is bullish on Alembic Pharma has recommended buy rating on the stock with a target price of Rs 1180 in its research report dated July 22, 2020.

  • Neutral Alembic Pharma; target of Rs 1122: Motilal Oswal Jul 23, 2020 07:03 PM IST

    Neutral Alembic Pharma; target of Rs 1122: Motilal Oswal

    Motilal Oswal recommended Neutral rating on Alembic Pharma with a target price of Rs 1122 in its research report dated July 22, 2020.

  • Alembic Pharma Standalone June 2020 Net Sales at Rs 1,258.43 crore, up 40.33% Y-o-Y Jul 23, 2020 09:31 AM IST

    Alembic Pharma Standalone June 2020 Net Sales at Rs 1,258.43 crore, up 40.33% Y-o-Y

  • Alembic Pharma expects domestic biz to grow in double digits in the current fiscal Jul 12, 2020 01:21 PM IST

    Alembic Pharma expects domestic biz to grow in double digits in the current fiscal

    "We completed this transition in 2019-20 and started witnessing an uptick in performance in the last quarter of the fiscal," Alembic Pharmaceuticals Managing Directors Pranav Amin and Shaunak Amin said in a joint communication.

  • Alembic Pharma gets USFDA nod for generic Doxycycline Hyclate tablets Jul 01, 2020 03:15 PM IST

    Alembic Pharma gets USFDA nod for generic Doxycycline Hyclate tablets

    The company's product is a generic version of Almirall, LLC's Acticlate tablets in the same strengths, Alembic Pharma said in a BSE filing.

  • Buy Alembic Pharma; target of Rs 1100: YES Securities Jun 23, 2020 06:48 PM IST

    Buy Alembic Pharma; target of Rs 1100: YES Securities

    YES Securities is bullish on Alembic Pharma has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated June 15, 2020.

  • Alembic Pharmaceuticals gets USFDA nod for generic acne treatment gel Jun 19, 2020 02:16 PM IST

    Alembic Pharmaceuticals gets USFDA nod for generic acne treatment gel

    The approved product is a generic version of Galderma Laboratories LP's Differin gel in the same strength, it added.

Sections